28.12.2012 Views

THE FUTURE, - Solvay

THE FUTURE, - Solvay

THE FUTURE, - Solvay

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

206492 209151<br />

CARDIOMETABOLIC RESIDUAL RISK<br />

REDUCTION INITIATIVES (R³I)<br />

Raising awareness about<br />

RVR<br />

<strong>THE</strong> PROJECT. Despite current standards<br />

of care, millions of patients with heart disease<br />

and/or diabetes remain exposed to a high<br />

residual risk (RR) of macro-vascular events<br />

(heart attack, stroke), and diabetic micro-vascular<br />

complications. This is the Residual Vascular Risk<br />

(RVR).<br />

Atherogenic dyslipidemia (high TG and low HDL-c)<br />

is a strong contributor to macro-vascular RR and<br />

is also implicated in diabetic micro-vascular<br />

complications, and is unaddressed by standard<br />

care procedures which include statins.<br />

The future growth of the <strong>Solvay</strong> fenofi brate-based<br />

treatment will come from the RVR market, with<br />

the co-prescription of statins.<br />

In order to substantially improve and prolong the<br />

lives of dyslipidamic patients with heart disease<br />

and/or diabetes, but also to develop the RVR<br />

market and maximize the business potential of<br />

the fenofranchise, <strong>Solvay</strong> Pharmaceuticals<br />

designed, built and funds a unique and global<br />

organization, the Residual Risk Reduction Initiative<br />

(R 3 i), aiming at raising awareness and driving the<br />

need to treat the RVR in these patients.<br />

This is a unique, innovative research and<br />

educational initiative with global and national<br />

organizations in over 40 countries worldwide<br />

which is able to educate wider physicians’<br />

audiences, accelerate changes in physician<br />

prescribing behaviors in a cost-effective way,<br />

and signifcantly develop <strong>Solvay</strong> awareness and<br />

credibilty in the cardio-metabolic area.<br />

PHARMACEUTICALS SECTOR<br />

> François Beucher; Patrick Aubonnet;<br />

Charles Galleano; Chantal Vekens.<br />

COMPOUNDS FOR “BI-ORIENTED” PIPES<br />

PVC pipes: more fl exible<br />

and more durable<br />

<strong>THE</strong> PROJECT. Certain “bi-oriented” pipes<br />

have been made out of steel until now.<br />

In collaboration with our customer, we have<br />

developed the formula for a compound that allows<br />

us to produce (by extrusion) this kind of pipe in<br />

PVC. That means a whole new market for PVC<br />

compounds.<br />

The PVC compound formulation for these<br />

bi-oriented pipes with very specifi c applications<br />

was not available on the market until now, and<br />

requires a deep knowledge in additivation.<br />

These kinds of bi-oriented PVC pipes offer<br />

considerable advantages as they are much more<br />

fl exible and their life time is signifi cantly<br />

increased.<br />

Furthermore, the PVC compound material is<br />

cheaper than steel!<br />

SBU VINYLS<br />

> Hanns Ammann; Juan Gonzalez-Valero.<br />

209729<br />

WORLD’S LIGHTEST CLOSED LOOP-<br />

RECYCLABLE FULL POLYMER (RADEL ® R)<br />

RFID-EQUIPPED AIRLINE CATERING TROLLEY<br />

Lightweight, durable<br />

and totally recyclable<br />

<strong>THE</strong> PROJECT. Airlines are increasingly looking to<br />

reduce the weight of embarked items, for obvious<br />

reasons of fuel savings and CO 2 emissions reductions.<br />

Aerocat, a full-service trolley manufacturer, formed a<br />

strategic alliance with key industry players, including<br />

<strong>Solvay</strong>, to develop a brand new generation of<br />

lightweight (25% weight less than aluminum) and fully<br />

recyclable trolleys, under the brand name Tigris. The<br />

material used, Radel ® R, complies with the stringent<br />

aircraft interiors regulations in terms of fl ammability,<br />

smoke and toxicity.<br />

Strong support from <strong>Solvay</strong> Advanced Polymers<br />

technical services has permitted the success in the<br />

manufacturing of the parts, which are considered the<br />

largest injection and extrusion thin walled parts ever<br />

seen in high temperature thermoplastics. The selected<br />

design allows high assembling production rates,<br />

avoids the use of fasteners, and provides a robust fi nal<br />

product that withstands loads up to 150 kg, which is a<br />

fi rst. Moreover, a full Radel ® R trolley allows the use of<br />

the RFID tracking system, facilitating the good<br />

management of trolleys and their contents. At the end<br />

of the trolley’s life cycle, Radel ® R parts can be ground<br />

and reused in new trolleys, permitting a reduction of<br />

carbon footprint by a factor of 2.2 versus the current<br />

aluminum trolleys.<br />

Demand for over 60 000 trolleys is foreseen by 2011.<br />

This innovation technology is already interesting other<br />

industries for parts such as galleys and meal boxes in<br />

aircraft, and other applications can be foreseen for<br />

other transport industries, such as rail and sea.<br />

SBU SPECIALTY POLYMERS<br />

> Margarita Alonso; Brian Alexander; Kalvis Cers;<br />

Amy Cuevas; James Hicks; Bob Hirsch;<br />

Ronald Lupardus; William Madden;<br />

Michel Magdelyns; Sébastien Pétillon; Jason Ross.<br />

<strong>Solvay</strong> <strong>Solvay</strong> live live - JUILLET - JULY 2009 2009 - - 27

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!